<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Nanxi Wang</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0016542000</full_dataset_link><submitter_email>nanxi.wang@njucm.edu.cn</submitter_email><submitter_affiliation>Nanjing University of Chinese Medicine</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Genetic code expansion enables site-specific acetylation to reprogram Lunasin toward BRD4 targeting</name><description>Lunasin is a plant-derived peptide with moderate anticancer activity but has limited potency and undefined molecular targets. To enhance its functional properties, we developed a site-specifically acetylated variant (Lunasin-K29ac) via genetic code expansion. To characterize the molecular interactions underlying its enhanced activity, we performed interactome profiling of a control (pET-22b-CBD), wild-type Lunasin, and Lunasin-K29ac in HT-29 cells using His pull-down MS.</description><dates><publication>Tue Apr 07 00:00:00 GMT+01:00 2026</publication></dates><accession>PXD076719</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>